Option Care Health, Inc. (NASDAQ:OPCH) Shares Sold by Swiss National Bank

Swiss National Bank trimmed its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 0.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 336,400 shares of the company’s stock after selling 2,900 shares during the period. Swiss National Bank owned about 0.20% of Option Care Health worth $7,804,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of OPCH. Westfield Capital Management Co. LP lifted its holdings in shares of Option Care Health by 10.2% during the 3rd quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after acquiring an additional 599,589 shares in the last quarter. Graypoint LLC acquired a new position in shares of Option Care Health during the fourth quarter worth about $1,161,000. Charles Schwab Investment Management Inc. boosted its position in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after buying an additional 147,054 shares during the period. Global Alpha Capital Management Ltd. grew its stake in shares of Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock valued at $1,596,000 after buying an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Option Care Health during the 4th quarter valued at about $327,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the business’s stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total transaction of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. The trade was a 40.80 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Trading Up 0.8 %

NASDAQ:OPCH opened at $34.58 on Friday. The company has a market cap of $5.72 billion, a PE ratio of 29.06, a P/E/G ratio of 2.30 and a beta of 1.33. The business’s 50 day moving average is $31.84 and its two-hundred day moving average is $28.32. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $34.85.

Analyst Ratings Changes

OPCH has been the subject of several recent research reports. JPMorgan Chase & Co. increased their price objective on shares of Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price target for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. UBS Group assumed coverage on shares of Option Care Health in a research report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price objective for the company. JMP Securities reiterated a “market outperform” rating and issued a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Finally, Barrington Research raised their price objective on Option Care Health from $33.00 to $38.00 and gave the company an “outperform” rating in a research note on Thursday, February 27th. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $33.00.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.